Factorial Partners LLC Has $939,000 Stake in Phibro Animal Health Co. (NASDAQ:PAHC)

Factorial Partners LLC reduced its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 26.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 56,000 shares of the company’s stock after selling 20,200 shares during the quarter. Factorial Partners LLC owned 0.14% of Phibro Animal Health worth $939,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Brandes Investment Partners LP grew its holdings in shares of Phibro Animal Health by 13.7% in the 4th quarter. Brandes Investment Partners LP now owns 2,130,107 shares of the company’s stock worth $24,667,000 after purchasing an additional 256,807 shares during the last quarter. Acadian Asset Management LLC increased its holdings in shares of Phibro Animal Health by 6.3% during the second quarter. Acadian Asset Management LLC now owns 717,506 shares of the company’s stock worth $12,027,000 after buying an additional 42,299 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Phibro Animal Health by 165.9% in the fourth quarter. Wellington Management Group LLP now owns 164,764 shares of the company’s stock valued at $1,908,000 after acquiring an additional 102,793 shares during the last quarter. Bridge City Capital LLC boosted its holdings in shares of Phibro Animal Health by 3.3% in the 1st quarter. Bridge City Capital LLC now owns 137,694 shares of the company’s stock worth $1,780,000 after acquiring an additional 4,433 shares in the last quarter. Finally, Principal Financial Group Inc. grew its position in Phibro Animal Health by 8.4% during the 1st quarter. Principal Financial Group Inc. now owns 114,869 shares of the company’s stock worth $1,485,000 after acquiring an additional 8,884 shares during the last quarter. 99.34% of the stock is owned by institutional investors.

Phibro Animal Health Stock Up 1.7 %

Shares of PAHC opened at $20.88 on Wednesday. The business’s fifty day moving average price is $18.66 and its two-hundred day moving average price is $16.45. The firm has a market capitalization of $845.64 million, a price-to-earnings ratio of 65.25, a PEG ratio of 1.54 and a beta of 0.52. Phibro Animal Health Co. has a 52 week low of $9.40 and a 52 week high of $22.31. The company has a debt-to-equity ratio of 1.79, a quick ratio of 1.64 and a current ratio of 2.94.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Wednesday, September 4th will be given a $0.12 dividend. The ex-dividend date is Wednesday, September 4th. This represents a $0.48 dividend on an annualized basis and a yield of 2.30%. Phibro Animal Health’s payout ratio is 150.00%.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the company. JPMorgan Chase & Co. initiated coverage on Phibro Animal Health in a research report on Tuesday. They issued a “neutral” rating and a $22.00 price objective for the company. Bank of America lifted their price target on Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a report on Friday, August 30th. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $15.00.

Insider Buying and Selling

In other Phibro Animal Health news, Director E Thomas Corcoran purchased 5,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 4th. The stock was acquired at an average cost of $20.02 per share, with a total value of $100,100.00. Following the completion of the purchase, the director now directly owns 25,000 shares in the company, valued at approximately $500,500. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 50.06% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.